Withdrawal of a drug from the market: what should the prescriber do?
Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine
Letter to the Editor
Drug Approval; Drug Utilization; Product Surveillance, Postmarketing; United States; United States Food and Drug Administration
Health Services Research | Medicine and Health Sciences
JAMA. 1994 Oct 26;272(16):1253.
JAMA : the journal of the American Medical Association
Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. (1994). Withdrawal of a drug from the market: what should the prescriber do?. Meyers Primary Care Institute Publications. Retrieved from https://escholarship.umassmed.edu/meyers_pp/151